RECURSION PHARMACEUTICALS IN's ticker is RXRX and the CUSIP is 75629V104. A total of 158 filers reported holding RECURSION PHARMACEUTICALS IN in Q1 2023. The put-call ratio across all filers is 0.85 and the average weighting 0.9%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kinnevik AB (publ) | 7,653,061 | $51,045,917 | 68.47% |
| Data Collective IV GP, LLC | 5,941,120 | $39,627,270 | 42.23% |
| MV Management XI, L.L.C. | 1,971,908 | $13,152,626 | 20.13% |
| MIC Capital Management UK LLP | 8,451,758 | $56,373,229 | 10.75% |
| ArchPoint Investors | 1,114,626 | $7,434,555 | 3.23% |
| HARVARD MANAGEMENT CO INC | 1,509,254 | $10,066,724 | 1.06% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 2,770,451 | $18,478,908 | 0.64% |
| Duquesne Family Office | 1,385,950 | $9,259 | 0.40% |
| ALLEN OPERATIONS LLC | 217,657 | $1,451,772 | 0.37% |
| Cercano Management LLC | 978,051 | $6,523,600 | 0.26% |
| Comprehensive Financial Management LLC | 1,109,395 | $7,399,665 | 0.22% |
| HAMILTON LANE ADVISORS LLC | 96,474 | $643 | 0.22% |
| Laurion Capital Management LP | 4,825,735 | $32,187,653 | 0.22% |
| Delphia (USA) Inc. | 26,470 | $176,555 | 0.22% |
| ARK Investment Management | 3,576,862 | $23,857,670 | 0.16% |
| Corton Capital Inc. | 32,661 | $217,849 | 0.15% |
| Baillie Gifford | 25,135,530 | $167,653,985 | 0.15% |
| Bienville Capital Management, LLC | 56,876 | $379,363 | 0.14% |
| Cypress Point Wealth Management, LLC | 14,219 | $94,841 | 0.13% |
| Values First Advisors, Inc. | 30,289 | $202,025 | 0.13% |
External links
This page lists RECURSION PHARMACEUTICALS IN's shareholders in Q1 2023. To view RECURSION PHARMACEUTICALS IN's shareholder history, click here.